EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Clinical, Endoscopic, and Histopathologic Observations in Gastrointestinal Amyloidosis

Lea U Krauß, Stephan Schmid, Patricia Mester, Kirsten Utpatel, Claudia Kunst, Martina Müller, Vlad Pavel

Journal of Gastrointestinal and Liver Diseases · 22.12.2023 · 32 (4) · 497-506

DOI: 10.15403/jgld-5107 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gastrointestinal and Liver Diseases, online erschienen am 22.12.2023. Verfasst von Lea U Krauß und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious diseases, University Hospital Regensburg…. Hauptthemen laut MEDLINE: Gastrointestinal Diseases, Amyloidosis. Die Arbeit wurde bisher 17-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims: Amyloidosis is a group of systemic disorders caused by extracellular deposition of misfolded serum proteins. Gastrointestinal (GI) involvement is associated with a higher risk of GI bleeding, especially if mucosal lesions are present. Our study aims to evaluate the frequency of GI manifestations in patients with amyloidosis, to clinically characterize these patients and to describe the endoscopic and histopathologic findings in GI amyloidosis.

Methods

A retrospective, single-center study of all patients admitted with amyloidosis and GI manifestations was conducted at a German University Hospital between July 2003 and June 2023. Clinical, endoscopic, and histopathological data was retrieved from medical records.

Results

Between July 2003 and June 2023, 63 patients with different types of amyloidosis were included into the study. Twenty-three (36,5%) were diagnosed with GI involvement of amyloidosis (60.9% male, median age 62 ± 18.28 years). The distribution of the types of amyloidosis were amyloid light chain (AL) at 52.5%, transthyretin (ATTR) at 21.7%, amyloid A (AA) at 13.0%, and unknown at 18%. Initial GI symptoms were present in 78.3% of the patients and included mainly diarrhea (34.8%), and abdominal pain (30.4%) Affected GI organs were primarily the colon (60,8%) and the stomach (39.1%). Endoscopic findings were ulcerations (47.8%), mucosal inflammation (43.5%), polyps (26.1%), erosions (13.0%), vascular malformation, polypoid protrusion, submucosal hematoma, erythema, metaplasia, and diverticulum. Histopathological findings included vascular wall thickening, (peri-)vascular and interstitial amyloid deposition. Gastrointestinal bleeding occurred in 39.1% of the patients. The mortality rate 5 years after diagnosis was 47.8%.

Conclusions

Gastrointestinal amyloidosis can present with multiple symptoms and endoscopic findings, rendering diagnosis a challenge. Of clinical relevance, GI bleeding was a frequent event in our patient cohort. Therefore, clinicians must be aware of GI bleeding as a manifestation of amyloidosis and definite diagnosis should be achieved based on biopsy results.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal DiseasesAmyloidosisHumansMaleAdultMiddle AgedAgedAged, 80 and overFemaleRetrospective StudiesGastrointestinal Hemorrhage

Autor:innen und Institutionen

  • Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious diseases, University Hospital Regensburg, Regensburg, Germany. . Lea.Krauss@ukr.de.
  • Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious diseases, University Hospital Regensburg, Regensburg, Germany. . Stephan.Schmid@ukr.de.
  • Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious diseases, University Hospital Regensburg, Regensburg, Germany. Patricia.Mester@ukr.de.
  • Institute of Pathology, University of Regensburg, Regensburg, Germany. Kirsten.Utpatel@ukr.de.
  • Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious diseases, University Hospital Regensburg, Regensburg, Germany. Claudia.Kunst@ukr.de.
  • Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious diseases, University Hospital Regensburg, Regensburg, Germany. Martina.Mueller-Schilling@ukr.de.

Zitieren

APA

Krauß, L. U., Schmid, S., Mester, P., Utpatel, K., Kunst, C., Müller, M., & Pavel, V. (2023). Clinical, Endoscopic, and Histopathologic Observations in Gastrointestinal Amyloidosis. Journal of Gastrointestinal and Liver Diseases, 32(4), 497-506. https://doi.org/10.15403/jgld-5107

Vancouver

Krauß LU, Schmid S, Mester P, Utpatel K, Kunst C, Müller M, et al. Clinical, Endoscopic, and Histopathologic Observations in Gastrointestinal Amyloidosis. Journal of Gastrointestinal and Liver Diseases. 2023;32(4):497-506. doi:10.15403/jgld-5107

BibTeX
@article{Krau2023,
  author = {Krauß, Lea U and Schmid, Stephan and Mester, Patricia and Utpatel, Kirsten and Kunst, Claudia and Müller, Martina and Pavel, Vlad},
  title = {Clinical, Endoscopic, and Histopathologic Observations in Gastrointestinal Amyloidosis},
  journal = {Journal of Gastrointestinal and Liver Diseases},
  year = {2023},
  volume = {32},
  number = {4},
  pages = {497--506},
  doi = {10.15403/jgld-5107}
}
Kostenlos starten →